Navigation Links
Purdue lab works to improve conditions at indoor swimming pools
Date:2/19/2008

lor change depending on the chemical makeup of the samples. The test, however, fails to distinguish between various types of chemical compounds.

"Basically, what we want to do is relate our measurements to the operating characteristics of the pool," Blatchley said. "To address this issue, we are collecting samples from a number of public pools and analyzing them to determine the concentrations of volatile disinfection byproducts that are present in operating pools."

That research is being conducted by three members of Blatchley's group: graduate students William Weaver and Yuli Wen and undergraduate student Jessica Johnston.

"We are also examining what can be done to the water to improve the chemistry once these chemicals have been formed," Blatchley said. "In other words, how can you break down the disinfection byproducts or prevent their formation""

New research is focusing on what happens when disinfection byproducts are treated with ultraviolet radiation. Findings indicate that some inorganic disinfection byproducts containing nitrogen that are subjected to ultraviolet radiation break down to "more or less innocuous compounds," Blatchley said.

The disinfection byproducts are converted to several compounds, including nitrates and nitrous oxide, also known as laughing gas.

"Currently, we know where about 75 percent of the nitrogen goes, and we think we know where most of the rest of it goes, but we need to do some experiments to confirm that," he said.

These findings also will shed light on what happens to drinking water when treated with ultraviolet radiation.

"Sometimes ultraviolet radiation and chlorine are used together to treat drinking water," Blatchley said. "The chemistry is very similar in both settings, so our interest in those reactions is broader than just swimming pools.

"We have a pretty good understanding of what UV radiation does to microorganisms, but what it does to
'/>"/>

Contact: Emil Venere
venere@purdue.edu
765-494-4709
Purdue University
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. Purdue researchers develop technology to detect cancer by scanning surface veins
2. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
3. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
4. Taxol bristle ball: a wrench in the works for cancer
5. Cancer control in Europe works; now it is time to extend it to poorer countries
6. SecureWorks Ranked 6th in Deloittes Technology Fast 50 Program for Georgia
7. AK Steel Reaches VEBA Health Care Settlement With Middletown Works Retirees
8. IOM workshop on less confusing drug labeling, Oct. 12
9. CIDM Collaborates With World Congress to Advance Dialog on Online Provider Networks at WHIT 3.0
10. Crittenton Hospital Medical Center to Participate in United Physicians myWorkspace(R) Initiative
11. MIT works toward novel therapeutic device
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Purdue lab works to improve conditions at indoor swimming pools
Purdue lab works to improve conditions at indoor swimming pools
Other Medicine News:Health News:Growth hormone is used to treat twice as many short boys than girls in the US and Asia 2Health News:Growth hormone is used to treat twice as many short boys than girls in the US and Asia 3Health News:Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower 2Health News:The Best Things in Life Are ... In Better Health & Living(R), A Free, Premium Magazine Launching April 26 in the Twin Cities 2Health News:The Best Things in Life Are ... In Better Health & Living(R), A Free, Premium Magazine Launching April 26 in the Twin Cities 3Health News:U-M study: Work hassles hamper sleep 2Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 2Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 3Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 4Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 5Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 6Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 7Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 8Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 9Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 10Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 11Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 12Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 13Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 14Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 15Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 16Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 17Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 18Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 19Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 20Health News:Arpida Provides Comprhensive Overview of Pivotal Phase III Trial Data 2Health News:Arpida Provides Comprhensive Overview of Pivotal Phase III Trial Data 3
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 1Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 2Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 3Beetroot Juice May Boost Stamina 53957 1Beetroot Juice May Boost Stamina 53957 2Insulet Corporation to Present at Upcoming Investor Conferences 53953 1Insulet Corporation to Present at Upcoming Investor Conferences 53953 2